PubMed

Can we become victims of our own success?

Buse JB.

Diabetes Care. 2009 Nov;32(11):2140-1. No abstract available. PMID: 19875611 [PubMed - in process]Related articles

How do we define cure of diabetes?

Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE, McLaughlin S, Phillips GL 2nd, Robertson RP, Rubino F, Kahn R, Kirkman MS.

Diabetes Care. 2009 Nov;32(11):2133-5. No abstract available. PMID: 19875608 [PubMed - in process]Related articles

Effects of therapy in type 1 and type 2 diabetes mellitus with a peptide derived from islet neogenesis associated protein (INGAP).

Dungan KM, Buse JB, Ratner RE.

Diabetes Metab Res Rev. 2009 Sep;25(6):558-65.PMID: 19626663 [PubMed - in process]Related articles

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).

Buse JB, Rosenstock J, Sesti G, Schmidt WE, Montanya E, Brett JH, Zychma M, Blonde L; LEAD-6 Study Group.

Lancet. 2009 Jul 4;374(9683):39-47. Epub 2009 Jun 8.PMID: 19515413 [PubMed - indexed for MEDLINE]Related articles

DURAbility of basal versus lispro mix 75/25 insulin efficacy (DURABLE) trial 24-week results: safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes.

Buse JB, Wolffenbuttel BH, Herman WH, Shemonsky NK, Jiang HH, Fahrbach JL, Scism-Bacon JL, Martin SA.

Diabetes Care. 2009 Jun;32(6):1007-13. Epub 2009 Mar 31.PMID: 19336625 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD).

Zinman B, Gerich J, Buse JB, Lewin A, Schwartz S, Raskin P, Hale PM, Zdravkovic M, Blonde L; LEAD-4 Study Investigators.

Diabetes Care. 2009 Jul;32(7):1224-30. Epub 2009 Mar 16.PMID: 19289857 [PubMed - indexed for MEDLINE]Related articlesFree article

Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes.

Herman WH, Dungan KM, Wolffenbuttel BH, Buse JB, Fahrbach JL, Jiang H, Martin S.

J Clin Endocrinol Metab. 2009 May;94(5):1689-94. Epub 2009 Mar 10.PMID: 19276235 [PubMed - indexed for MEDLINE]Related articles

Endothelial dysfunction: associations with exposure to ambient fine particles in diabetic individuals.

Schneider A, Neas L, Herbst MC, Case M, Williams RW, Cascio W, Hinderliter A, Holguin F, Buse JB, Dungan K, Styner M, Peters A, Devlin RB.

Environ Health Perspect. 2008 Dec;116(12):1666-74. Epub 2008 Jul 31.PMID: 19079718 [PubMed - indexed for MEDLINE]Related articlesFree article

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B; American Diabetes Association; European Association for Study of Diabetes.

Diabetes Care. 2009 Jan;32(1):193-203. Epub 2008 Oct 22.PMID: 18945920 [PubMed - in process]Related articlesFree article

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B; American Diabetes Association; European Association for the Study of Diabetes.

Diabetologia. 2009 Jan;52(1):17-30. Epub 2008 Oct 22.PMID: 18941734 [PubMed - indexed for MEDLINE]Related articles

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study.

Drucker DJ, Buse JB, Taylor K, Kendall DM, Trautmann M, Zhuang D, Porter L; DURATION-1 Study Group.

Lancet. 2008 Oct 4;372(9645):1240-50. Epub 2008 Sep 7.PMID: 18782641 [PubMed - indexed for MEDLINE]Related articles

Are prescribing patterns of antidiabetic medications influenced by fears of litigation?

Buse JB.

Nat Clin Pract Endocrinol Metab. 2008 Aug;4(8):440-1. Epub 2008 Jun 17. No abstract available. PMID: 18560400 [PubMed - indexed for MEDLINE]Related articles

Effects of intensive glucose lowering in type 2 diabetes.

Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT.

N Engl J Med. 2008 Jun 12;358(24):2545-59. Epub 2008 Jun 6.PMID: 18539917 [PubMed - indexed for MEDLINE]Related articlesFree article

A dead heat: target normal glucose levels in the intensive care unit--but with caution.

Buse JB.

Diabetologia. 2008 Jun;51(6):909-10. No abstract available. PMID: 18392805 [PubMed - indexed for MEDLINE]Related articles

Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial.

Farkouh ME, Dangas G, Leon MB, Smith C, Nesto R, Buse JB, Cohen DJ, Mahoney E, Sleeper L, King S 3rd, Domanski M, McKinlay S, Fuster V.

Am Heart J. 2008 Feb;155(2):215-23.PMID: 18215589 [PubMed - indexed for MEDLINE]Related articles

Frontline: diabetes--supplementing education and quality improvement in family medicine residency training.

Carek PJ, Buse JB; Association of Family Medicine Residency Directors.

Ann Fam Med. 2008 Jan-Feb;6(1):88-9. No abstract available. PMID: 18195323 [PubMed - indexed for MEDLINE]Related articlesFree article

Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B.

Diabetes Care. 2008 Jan;31(1):173-5. No abstract available. PMID: 18165348 [PubMed - indexed for MEDLINE]Related articlesFree article

Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.

Klonoff DC, Buse JB, Nielsen LL, Guan X, Bowlus CL, Holcombe JH, Wintle ME, Maggs DG.

Curr Med Res Opin. 2008 Jan;24(1):275-86.PMID: 18053320 [PubMed - indexed for MEDLINE]Related articles

Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones.

Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B.

Diabetologia. 2008 Jan;51(1):8-11. No abstract available. PMID: 18026926 [PubMed - indexed for MEDLINE]Related articles

A comparison of lipid and lipoprotein measurements in the fasting and nonfasting states in patients with type 2 diabetes.

Dungan KM, Guster T, DeWalt DA, Buse JB.

Curr Med Res Opin. 2007 Nov;23(11):2689-95.PMID: 17892636 [PubMed - indexed for MEDLINE]Related articles

Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Goff DC Jr, Gerstein HC, Ginsberg HN, Cushman WC, Margolis KL, Byington RP, Buse JB, Genuth S, Probstfield JL, Simons-Morton DG; ACCORD Study Group.

Am J Cardiol. 2007 Jun 18;99(12A):4i-20i. Epub 2007 Apr 12. Review.PMID: 17599424 [PubMed - indexed for MEDLINE]Related articles

Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods.

ACCORD Study Group, Buse JB, Bigger JT, Byington RP, Cooper LS, Cushman WC, Friedewald WT, Genuth S, Gerstein HC, Ginsberg HN, Goff DC Jr, Grimm RH Jr, Margolis KL, Probstfield JL, Simons-Morton DG, Sullivan MD.

Am J Cardiol. 2007 Jun 18;99(12A):21i-33i. Epub 2007 Apr 16.PMID: 17599422 [PubMed - indexed for MEDLINE]Related articles

Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia.

Deeg MA, Buse JB, Goldberg RB, Kendall DM, Zagar AJ, Jacober SJ, Khan MA, Perez AT, Tan MH; GLAI Study Investigators.

Diabetes Care. 2007 Oct;30(10):2458-64. Epub 2007 Jun 26.PMID: 17595355 [PubMed - indexed for MEDLINE]Related articlesFree article

Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials.

Buse JB, Klonoff DC, Nielsen LL, Guan X, Bowlus CL, Holcombe JH, Maggs DG, Wintle ME.

Clin Ther. 2007 Jan;29(1):139-53.PMID: 17379054 [PubMed - indexed for MEDLINE]Related articles

Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.

Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ; American Heart Association; American Diabetes Association.

Circulation. 2007 Jan 2;115(1):114-26. Epub 2006 Dec 27.PMID: 17192512 [PubMed - indexed for MEDLINE]Related articlesFree article

Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.

Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ; American Heart Association; American Diabetes Association.

Diabetes Care. 2007 Jan;30(1):162-72. Review.PMID: 17192355 [PubMed - indexed for MEDLINE]Related articlesFree article

Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B.

Diabetes Care. 2006 Aug;29(8):1963-72. No abstract available. Erratum in: Diabetes Care. 2006 Nov;49(11):2816-8. PMID: 16873813 [PubMed - indexed for MEDLINE]Related articlesFree article

Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B; Professional Practice Committee, American Diabetes Association; European Association for the Study of Diabetes.

Diabetologia. 2006 Aug;49(8):1711-21. No abstract available. PMID: 16802130 [PubMed - indexed for MEDLINE]Related articles

1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes.

Dungan KM, Buse JB, Largay J, Kelly MM, Button EA, Kato S, Wittlin S.

Diabetes Care. 2006 Jun;29(6):1214-9.PMID: 16731998 [PubMed - indexed for MEDLINE]Related articlesFree article

Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes.

Buse JB, Rubin CJ, Frederich R, Viraswami-Appanna K, Lin KC, Montoro R, Shockey G, Davidson JA.

Clin Ther. 2005 Aug;27(8):1181-95.PMID: 16199244 [PubMed - indexed for MEDLINE]Related articles

A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia.

Goldberg RB, Kendall DM, Deeg MA, Buse JB, Zagar AJ, Pinaire JA, Tan MH, Khan MA, Perez AT, Jacober SJ; GLAI Study Investigators.

Diabetes Care. 2005 Jul;28(7):1547-54.PMID: 15983299 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevention of cardiovascular outcomes in type 2 diabetes mellitus: trials on the horizon.

Buse JB, Rosenstock J.

Endocrinol Metab Clin North Am. 2005 Mar;34(1):221-35. Review.PMID: 15752929 [PubMed - indexed for MEDLINE]Related articles

Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change.

Grant RW, Buse JB, Meigs JB; University HealthSystem Consortium (UHC) Diabetes Benchmarking Project Team.

Diabetes Care. 2005 Feb;28(2):337-442.PMID: 15677789 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes.

Buse JB, Henry RR, Han J, Kim DD, Fineman MS, Baron AD; Exenatide-113 Clinical Study Group.

Diabetes Care. 2004 Nov;27(11):2628-35.PMID: 15504997 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of adjunctive thiazolidinedione therapy on blood lipid levels and glycemic control in patients with type 2 diabetes.

Peters Harmel AL, Kendall DM, Buse JB, Boyle PJ, Marchetti A, Lau H.

Curr Med Res Opin. 2004;20(2):215-23.PMID: 15006017 [PubMed - indexed for MEDLINE]Related articles

The effects of oral anti-hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetes.

Buse JB, Tan MH, Prince MJ, Erickson PP.

Diabetes Obes Metab. 2004 Mar;6(2):133-56. Review.PMID: 14746579 [PubMed - indexed for MEDLINE]Related articles

Prevention or delay of type 2 diabetes.

Sherwin RS, Anderson RM, Buse JB, Chin MH, Eddy D, Fradkin J, Ganiats TG, Ginsberg HN, Kahn R, Nwankwo R, Rewers M, Schlessinger L, Stern M, Vinicor F, Zinman B; American Diabetes Association; National Institute of Diabetes and Digestive and Kidney Diseases.

Diabetes Care. 2004 Jan;27 Suppl 1:S47-54. Review. No abstract available. PMID: 14693925 [PubMed - indexed for MEDLINE]Related articlesFree article

Should postprandial glucose be routinely measured and treated to a particular target? Connecting the two sides of the debate.

Buse JB.

Diabetes Care. 2003 Sep;26(9):2700-1. No abstract available. PMID: 12941749 [PubMed - indexed for MEDLINE]Related articlesFree article

Glitazones and heart failure: critical appraisal for the clinician.

Buse JB.

Circulation. 2003 Aug 26;108(8):e57. No abstract available. PMID: 12939247 [PubMed - indexed for MEDLINE]Related articlesFree article

Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes.

Kolterman OG, Buse JB, Fineman MS, Gaines E, Heintz S, Bicsak TA, Taylor K, Kim D, Aisporna M, Wang Y, Baron AD.

J Clin Endocrinol Metab. 2003 Jul;88(7):3082-9.PMID: 12843147 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker.

Buse JB, Freeman JL, Edelman SV, Jovanovic L, McGill JB.

Diabetes Technol Ther. 2003;5(3):355-63.PMID: 12828817 [PubMed - indexed for MEDLINE]Related articles

The insulin resistance syndrome and coronary artery disease.

Kendall DM, Sobel BE, Coulston AM, Peters Harmel AL, McLean BK, Peragallo-Dittko V, Buse JB, Fonseca VA, Hill JO, Nesto RW, Sunyer FX; Partners Against Insulin Resistance Advisory Panel.

Coron Artery Dis. 2003 Jun;14(4):335-48. Review.PMID: 12826934 [PubMed - indexed for MEDLINE]Related articles

Should postprandial glucose be routinely measured and treated to a particular target? No!

Buse JB.

Diabetes Care. 2003 May;26(5):1615-8. Review. No abstract available. PMID: 12716828 [PubMed - indexed for MEDLINE]Related articlesFree article

A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States.

Buse JB, Cavazzoni P, Hornbuckle K, Hutchins D, Breier A, Jovanovic L.

J Clin Epidemiol. 2003 Feb;56(2):164-70.PMID: 12654411 [PubMed - indexed for MEDLINE]Related articles

The prevention or delay of type 2 diabetes.

Sherwin RS, Anderson RM, Buse JB, Chin MH, Eddy D, Fradkin J, Ganiats TG, Ginsberg H, Kahn R, Nwankwo R, Rewers M, Schlessinger L, Stern M, Vinicor F, Zinman B; American Diabetes Association.

Diabetes Care. 2003 Jan;26 Suppl 1:S62-9. No abstract available. PMID: 12502620 [PubMed - indexed for MEDLINE]Related articlesFree article

Physician attitudes and practices and patient awareness of the cardiovascular complications of diabetes.

Merz CN, Buse JB, Tuncer D, Twillman GB.

J Am Coll Cardiol. 2002 Nov 20;40(10):1877-81.PMID: 12446074 [PubMed - indexed for MEDLINE]Related articles

Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial.

Grundy SM, Vega GL, McGovern ME, Tulloch BR, Kendall DM, Fitz-Patrick D, Ganda OP, Rosenson RS, Buse JB, Robertson DD, Sheehan JP; Diabetes Multicenter Research Group.

Arch Intern Med. 2002 Jul 22;162(14):1568-76.PMID: 12123399 [PubMed - indexed for MEDLINE]Related articlesFree article

Metabolic side effects of antipsychotics: focus on hyperglycemia and diabetes.

Buse JB.

J Clin Psychiatry. 2002;63 Suppl 4:37-41. Review.PMID: 11913675 [PubMed - indexed for MEDLINE]Related articles

Panel discussion on achieving glycemic control.

Buse JB, Einhorn D.

Postgrad Med. 2001 Dec;110(6 Suppl):20-5.PMID: 19667581 [PubMed - indexed for MEDLINE]Related articles

Treatment of postprandial hyperglycemia in type 2 diabetes.

Fasy EA, Buse JB.

Postgrad Med. 2001 Dec;110(6 Suppl):14-9.PMID: 19667580 [PubMed - indexed for MEDLINE]Related articles